Tel: +86 (0)571 8102-5280 Email: sales@molcore.com
Language : English 中文版 日本語

Cas Index 8

  1. Home
  2. Sitemap
  3. Cas Index 8

Recently searched keywords

88131-66-2, 131061-12-6, 1007463-50-4, 300851-88-1, 1212132-25-6, 1343343-57-6, 3608-57-9, 1106953-35-8, 42065-78-1, 1820613-23-7, 869299-70-7, 5743-49-7, 85096-04-4, 61477-96-1, 6638-64-8, 15205-62-6, 1006488-79-4, 1261893-64-4, 1368589-20-1, 1434128-54-7, 182182-26-9, 124941-87-3, 10490-22-9, 1137451-25-2, 1713265-25-8, 1807039-47-9, 113730-55-5, 1250782-97-8, 23827-91-0, 179411-83-7, 301222-60-6, 1353946-80-1, 107-07-3, 26580-58-5, 34490-39-6, 1804245-66-6, 1261534-88-6, 2183447-03-0, 118373-61-8, 1023559-02-5, 1217644-25-1, 1023540-34-2, 1248989-63-0, 1250346-92-9, 728919-15-1, 1804155-11-0, 91-20-3, 276694-19-0, 23448-86-4, 40508-01-8, 675844-41-4, 451485-72-6, 478258-24-1, 1111115-78-6, 16387-61-4, 98826-77-8, 99196-57-3, 2231674-12-5, 478065-01-9, 735303-62-5

Products Sitemap

Cas Index 8

Product Number Chemical Name Molecular Formula
MC2F6799 81850-06-8 | β-D-arabino-Adenosine, 2′-O-acetyl-N-benzoyl-P-(2-chlorophenyl)-5′-O-(9-phenyl-9H-xanthen-9-yl)-β-D-arabino-adenylyl-(3′→5′)-N-benzoyl-3′-O-[3-hydroxy-1,1,3,3-tetrakis(1-methylethyl)disiloxanyl]-, 2′-acetate (9CI)
MC2U6798 82169-00-4 | β-D-arabino-Adenosine, N-benzoyl-P-(2-chlorophenyl)-3′,5′-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-β-D-arabino-adenylyl-(2′→5′)-N-benzoyl-, 2′,3′-diacetate (9CI)
MCG86797 86632-10-2 | β-D-arabino-Hept-5-enofuranuronic acid, 1-[6-(benzoylamino)-9H-purin-9-yl]-1,5,6-trideoxy-, ethyl ester, 2,3-dibenzoate, (E)- (9CI) C35H29N5O8
MC28H796 86632-11-3 | β-D-arabino-Heptofuranuronic acid, 1-[6-(benzoylamino)-9H-purin-9-yl]-1,5,6-trideoxy-, ethyl ester, 2,3-dibenzoate (9CI) C35H31N5O8
MC2N6795 86632-12-4 | β-D-arabino-Heptofuranuronic acid, 1-(6-amino-9H-purin-9-yl)-1,5,6-trideoxy- (9CI) C12H15N5O5
MC286N94 86632-14-6 | β-D-arabino-Heptofuranuronic acid, 1-(6-amino-9H-purin-9-yl)-1,5,6-trideoxy-, ethyl ester (9CI) C14H19N5O5
MC286Y93 86632-15-7 | β-D-arabino-Heptofuranuronamide, 1-[6-(benzoylamino)-9H-purin-9-yl]-1,5,6-trideoxy-, 2,3-dibenzoate (9CI) C33H28N6O7
MC28N792 86632-17-9 | β-D-arabino-Heptofuranuronamide, 1-(6-amino-9H-purin-9-yl)-1,5,6-trideoxy- (9CI) C12H16N6O4
MCD86791 86632-18-0 | β-D-arabino-Heptofuranuronamide, 1-(6-amino-9H-purin-9-yl)-1,5,6-trideoxy-, 2,3-diacetate (9CI) C16H20N6O6
MCW86734 819805-90-8 | β-D-arabino-Cytidine, 5-fluoro-β-D-arabino-uridylyl-(3′→5′)-N-(1-oxooctadecyl)-, 2′,3′-diacetate (9CI)
MCD86733 847651-23-4 | β-D-Arabinofuranuronic acid, 1-(6-amino-9H-purin-9-yl)-1-deoxy-, methyl ester (9CI, ACI)
MCP86732 860293-50-1 | β-D-arabino-Cytidine, 2′-deoxy-5-fluorouridylyl-(3′→5′)-N-octadecyl- (9CI)
MC2C6715 82227-85-8 | β-D-arabino-Adenosine, β-D-arabino-adenylyl-(2′→5′)-adenylyl-(2′→5′)- (9CI)
MC286R14 88054-64-2 | β-D-arabino-Adenosine, β-D-arabino-adenylyl-(3′→5′)-β-D-arabino-adenylyl-(3′→5′)-β-D-arabino-adenylyl-(3′→5′)- (9CI)
MC2Z6706 830327-12-3 | β-D-arabino-Cytidine, 2′-deoxy-5-fluorouridylyl-(3′→5′)-N-[(9Z)-1-oxo-9-octadecenyl]-, 2′,3′-diacetate (9CI)
MC286B02 82227-82-5 | β-D-arabino-Adenosine, adenylyl-(2′→5′)-β-D-arabino-adenylyl-(2′→5′)- (9CI)
MC2R6700 81841-70-5 | β-D-arabino-Adenosine, β-D-arabino-adenylyl-(3′→5′)-β-D-arabino-adenylyl-(3′→5′)- (9CI)
MCU86698 88054-63-1 | β-D-arabino-Adenosine, β-D-arabino-adenylyl-(3′→5′)- (9CI)
MCS86686 89196-52-1 | β-D-erythro-Pentofuranuronamide, N-[4-(bromoacetyl)phenyl]-1,2-dideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)- (9CI) C18H18BrN3O6
MC28R685 89196-53-2 | β-D-erythro-Pentofuranuronamide, 1,2-dideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-N-[4-(iodoacetyl)phenyl]- (9CI) C18H18IN3O6
MCU86661 809290-43-5 | β-D-arabino-Uridine, P-(2-cyanoethyl)-5′-O-[(1,1-dimethylethyl)dimethylsilyl]thymidylyl-(3′→5′)-3′-O-[(1,1-dimethylethyl)dimethylsilyl]-2′-O-2-propenyl- (9CI)
MC2W6660 809290-44-6 | β-D-arabino-Uridine, P-(2-cyanoethyl)-5′-O-[(1,1-dimethylethyl)dimethylsilyl]-2′-O-2-propenyluridylyl-(3′→5′)-3′-O-[(1,1-dimethylethyl)dimethylsilyl]-2′-O-2-propenyl- (9CI)
MCY86659 849116-61-6 | β-D-erythro-Hexofuranothymidine, 5′-O-benzoyl-3′-O-dephosphinicothymidylyl(methylimino)-(3′→6′)-5′,6′-dideoxy-3′-O-[(1,1-dimethylethyl)diphenylsilyl]- (9CI)
MC2Y6658 849132-32-7 | β-D-erythro-Hexofuranoadenosine, 3′-O-dephosphinicothymidylyl(methylimino)-(3′→6′)-2′,5′,6′-trideoxy-3′-O-[(1,1-dimethylethyl)diphenylsilyl]- (9CI)
MC2B6657 849133-24-0 | β-D-erythro-Hexofuranocytidine, 3′-O-dephosphinicothymidylyl(methylimino)-(3′→6′)-2′,5′,6′-trideoxy-3′-O-[(1,1-dimethylethyl)diphenylsilyl]- (9CI)
MCN86656 849137-05-9 | β-D-erythro-Hexofuranoguanosine, 3′-O-dephosphinicothymidylyl(methylimino)-(3′→6′)-2′,5′,6′-trideoxy-3′-O-[(1,1-dimethylethyl)diphenylsilyl]- (9CI)
MC28M642 80647-04-7 | β-D-erythro-Pentofuranuronamide, N-[4-(chloroacetyl)phenyl]-1,2-dideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)- (9CI) C18H18ClN3O6
MC2M6625 849116-16-1 | β-D-erythro-Hexofuranothymidine, 5′-deoxy-3′-O-dephosphinico-5′-iodothymidylyl(methylimino)-(3′→6′)-5′,6′-dideoxy-3′-O-[(1,1-dimethylethyl)diphenylsilyl]- (9CI)
MC2N6623 849179-17-5 | β-D-erythro-Hexofuranothymidine, 3′-S-dephosphinico-5′-O-[(4-methoxyphenyl)diphenylmethyl]-3′-thiothymidylyl(methylimino)-(3′→6′)-5′,6′-dideoxy-, 3′-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI)
MC2Y6622 849200-69-7 | β-D-erythro-Hexofuranothymidine, 3′-O-dephosphinicothymidylyl(methylimino)-(3′→6′)-5′,6′-dideoxy-3′-O-dephosphinico-β-D-erythro-hexofuranothymidylyl(methylimino)-(3′→6′)-5′,6′-dideoxy-3′-O-[(1,1-dimethylethyl)diphenylsilyl]- (9CI)

© Copyright 2015-2025 Hangzhou MolCore BioPharmatech Co.,Ltd. All rights reserved.